Skip to main content
. 2015 Feb 20;125(15):2386–2396. doi: 10.1182/blood-2014-09-600643

Table 1.

Table of patient characteristics

Patient ID Time point Age, y Sex Blast count at diagnosis, ×109/L Cytogenetics
P1 Diagnosis 1 M 92 ins(X;11) MLL rearrangement
P2 Diagnosis 74 F 72 Complex, dup 3q, FLT3−, NPM1−
P3 Diagnosis 73 F 16 Complex, 5q−, FLT3−, NPM1−
P4 Diagnosis 63 M 43 Normal
P5 Diagnosis 6 M 9 Inv(16)(p13;1q22) CBFB-MYH11
P6 Diagnosis 6 M 16 Monosomy 7
P7 Relapse 77 F 60 Del(16), Monosomy 7, FLT3-NPM1−
P8 Diagnosis 20 F 7 t(8;21)
P9 Diagnosis 22 F 13 Abnormal 7q and 17p, FLT3−, NPM1−
P10 Diagnosis 5 F 54 Normal
P11 Diagnosis 93 M 4 Normal
P12 Diagnosis 69 M 33 Normal
P13 Diagnosis 77 F 5 Normal
P14 Relapse 58 M 47 Normal
P15 Diagnosis 79 M 58 Normal
P16 Diagnosis 76 M 31 Normal
P17 Diagnosis 0.5 F 275 t(9;11)(p22;q23); MLLT3-KMT2A
P18 Diagnosis 53 F 54 Normal
P19 Relapse 68 M 94 Trisomy 11, FLT3−
P20 Relapse 63 M 87 Normal

MLL, mixed-lineage leukemia.